Wells Fargo lowered the firm’s price target on Centene (CNC) to $35 from $41 and keeps an Equal Weight rating on the shares. The firm notes results in Q3 were better than it feared and Centene increased EPS guidance modestly. However, the outlook for enhanced subsidy extension has weighed on the stock as visibility to earrings recovery worsens, Wells adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- OSCR, ELV, CNC: Health Insurer Stocks on Watch as Trump Pushes ACA Funds Directly to Americans
- Centene to Present at UBS 2025 Healthcare Conference
- Centene backs FY25 adjusted EPS view ‘at least’ $2.00, consensus $1.96
- Midday Fly By: Insurers slip as Senate spending bill lacks ACA extension
- Trump Trade: Trump says ‘enrichment’ of health insurers ‘must stop’